BRCA2 and prostate carcinoma: Deleterious germline variants of BReast CAncer susceptibility genes BRCA1 and BRCA2 (BRCA) significantly increase the risk of developing “BRCA mutation”-related tumors, including breast, ovarian, pancreatic, and prostate cancer [1].